‘We’re Not In The Market For Gimmicks’ – RB's Head Of Disruptive Innovation On Personalization And Digital Health

HBW Insight speaks exclusively to Reckitt Benckiser’s R&D Director, Global Health Disruptive Innovation, Dr John Creek about the firm's new innovation strategy, which involves partnering with entrepreneurs, start-ups and SMEs to create the next generation of personalised and digitally-enabled consumer healthcare brands. 

Light bulb in hand with brain
• Source: Shutterstock

“Doing more of the same is simply not an option,” insists Reckitt Benckiser Group PLC in its recent report on the future of the global consumer health market.

Disruptive change driven by healthcare start-ups offering personalization and digitization is ripping up the rule book, RB warns, and the big OTC players need to get

More from Digital Technologies

More from HBW Insight

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Beauty Industry Not Taking Advantage Of CBP’s Duty Drawback – IBA Conference

 

US Customs and Border Protection’s program allowing companies to recoup fees for imported goods that were destroyed or exported is applicable in the case of most of President Trump’s reciprocal tariffs. However, most cosmetic companies don’t make use of it.

Kennedy Defends Spending Cuts During Contentious Senate Hearing On HHS Budget

 
• By 

Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.